Caplin Point Laboratories Revenue and Competitors

MAS, TN USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Caplin Point Laboratories's estimated annual revenue is currently $275.8M per year.(i)
  • Caplin Point Laboratories's estimated revenue per employee is $221,682

Employee Data

  • Caplin Point Laboratories has 1244 Employees.(i)
  • Caplin Point Laboratories grew their employee count by 10% last year.

Caplin Point Laboratories's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
COOReveal Email/Phone
3
Capex procurement - officerReveal Email/Phone
4
Business Development OfficerReveal Email/Phone
5
Managing DirectorReveal Email/Phone
6
Managing DirectorReveal Email/Phone
7
Deputy ManagerReveal Email/Phone
8
Assistant ManagerReveal Email/Phone
9
Assistant ManagerReveal Email/Phone
10
Environment, Health and Safety ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A525%N/AN/A
#2
$145.5M5170%$28.5MN/A
#3
$102.7M4220%N/AN/A
#4
$58.7M2556%N/AN/A
#5
$8.2M41-2%N/AN/A
#6
$22.5M11212%$23.6MN/A
#7
$5.6M244%N/AN/A
#8
$11.3M5928%N/AN/A
#9
$13.1M657%N/AN/A
#10
$7.6M3616%N/AN/A
Add Company

What Is Caplin Point Laboratories?

Caplin Point Laboratories Limited is a niche Pharmaceutical Public Limited Company head quartered in Chennai, India, manufacturing a wide range of Pharmaceutical Formulations. Unique Business Model catering predominantly to emerging markets in Latin America, Africa, and South East Asia. - Holds over 1600 product registrations. - Strategic end to end business model. - Dedicated presence in 21 countries. 3 Manufacturing Locations: - Pondicherry – Focus on tablets, capsules, granules, liquid orals, ointments and creams. Recent expansion in the areas of suppositories, soft gelatin capsules and Penems. - Baddi - Focusing on tablets, capsules, granules, liquids orals, ointments and creams. - Chennai – Sterile Manufacturing Facility for Regulated Markets like USA, Europe, Brazil, Russia, South Africa & Australia. - R&D Centre in Chennai – Focusses on developing & improving existing dosage forms. Caplin Point features in “FORBES ASIA”. Best under a Billion List for Second consecutive year. Sterile Small Volume Liquid Injectable facility is approved by EU-GMP.

keywords:N/A

N/A

Total Funding

1244

Number of Employees

$275.8M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$275.8M124410%N/A